1. Home
  2. CSTL vs VLRS Comparison

CSTL vs VLRS Comparison

Compare CSTL & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • VLRS
  • Stock Information
  • Founded
  • CSTL 2007
  • VLRS 2005
  • Country
  • CSTL United States
  • VLRS Mexico
  • Employees
  • CSTL N/A
  • VLRS N/A
  • Industry
  • CSTL Medical Specialities
  • VLRS Air Freight/Delivery Services
  • Sector
  • CSTL Health Care
  • VLRS Consumer Discretionary
  • Exchange
  • CSTL Nasdaq
  • VLRS Nasdaq
  • Market Cap
  • CSTL 561.9M
  • VLRS 546.3M
  • IPO Year
  • CSTL 2019
  • VLRS N/A
  • Fundamental
  • Price
  • CSTL $16.53
  • VLRS $4.53
  • Analyst Decision
  • CSTL Strong Buy
  • VLRS Strong Buy
  • Analyst Count
  • CSTL 6
  • VLRS 6
  • Target Price
  • CSTL $37.67
  • VLRS $8.35
  • AVG Volume (30 Days)
  • CSTL 396.8K
  • VLRS 746.7K
  • Earning Date
  • CSTL 08-04-2025
  • VLRS 07-22-2025
  • Dividend Yield
  • CSTL N/A
  • VLRS N/A
  • EPS Growth
  • CSTL N/A
  • VLRS N/A
  • EPS
  • CSTL N/A
  • VLRS 0.04
  • Revenue
  • CSTL $347,083,000.00
  • VLRS $3,052,207,000.00
  • Revenue This Year
  • CSTL N/A
  • VLRS $2.04
  • Revenue Next Year
  • CSTL $1.36
  • VLRS $12.38
  • P/E Ratio
  • CSTL N/A
  • VLRS $13.04
  • Revenue Growth
  • CSTL 38.43
  • VLRS N/A
  • 52 Week Low
  • CSTL $15.45
  • VLRS $3.49
  • 52 Week High
  • CSTL $35.84
  • VLRS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 34.83
  • VLRS 49.52
  • Support Level
  • CSTL $19.29
  • VLRS $4.59
  • Resistance Level
  • CSTL $20.26
  • VLRS $4.95
  • Average True Range (ATR)
  • CSTL 0.70
  • VLRS 0.21
  • MACD
  • CSTL -0.35
  • VLRS -0.01
  • Stochastic Oscillator
  • CSTL 4.44
  • VLRS 44.83

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: